Article digest · Oct 4 AM

AI in Medicine — what each story says

Every story in this issue with a short summary, so you can decide what to read before leaving the site. Summaries are written by AI (Claude) only from each publisher's own description and checked by Jev for anything not in that description. They are not full translations. Follow "Read the original" for the full story.

21 stories11 with summaries7 topics

🩻 Diagnosis and imaging4

Intelligent Living10/03 09:39 UTC

AI ECG: The Smartphone Tool That Spots a Hidden Heart Disease

Yale's AI ECG tool flags cardiac amyloidosis from a simple photo of a heart trace. The disease carries a five-year life expectancy when untreated.

Read the original →

🩺 Clinical decision support4

Mirage News10/03 13:02 UTC

AAP Issues Guidance on Generative AI Use by Clinicians

The American Academy of Pediatrics has published guidance for pediatricians on the safe, equitable, and effective use of generative AI.

Read the original →
Digital Health Wire10/03 01:08 UTC

Integrating Consumer AI Into Healthcare Pathways

The article questions whether AI has truly recommended the right care if nobody is around to act on it. It attributes the view to Topol, who does not think so.

Read the original →
Pulse 2.010/02 15:32 UTC

Mount Sinai And Hasso Plattner Institute Launch Graduate Exchange Program For Digital Health And AI

The Icahn School of Medicine at Mount Sinai and the Hasso Plattner Institute for Digital Engineering have launched a graduate student exchange program. It focuses on artificial intelligence, digital health, biomedical informatics and data-driven healthcare innovation.

Read the original →

🏥 Hospital operations and care delivery2

WIRED10/02 09:30 UTC

AI Is Making a Mess of Nurses’ Schedules. They Say It’s a Safety Issue

A hospital giant and a radiology network turned to Palantir to streamline scheduling. Nurses and other staff say the new software is causing errors, burnout and frustration.

Read the original →

💊 Drug discovery and clinical trials5

finance.biggo.com10/03 10:06 UTC

AI Advances into Biotech R&D: Microsoft's Quine Sparks a Race Among Tech Giants

AI for Science (AI4S) has become a new battleground for tech giants. Microsoft Research has unveiled Quine, an experimental multimodal system.

Read the original →
FOX One10/03 00:31 UTC

Watch How AI agents, stock trading bots, and biotech are shaping the market - Barron's Roundtable

Jack Otter and the Barron's Roundtable panel discuss the $10 trillion AI agent turf war between Meta and Apple. They also evaluate the performance of AI stock trading bots and share biotech stock picks Gilead Sciences and Veeva Systems.

Read the original →
CMC Markets10/02 18:54 UTC

SDGR Stock: Schrödinger Hopes Its AI Agent Can Transform Drug Discovery

Schrödinger’s Bunsen AI agent could accelerate drug discovery. Growing software ACV and pharma milestones offer further upside for SDGR stock.

Read the original →

⚖️ Device approvals and regulation2

⚠️ Safety, errors and bias1

The New Times10/03 12:20 UTC

Africa CDC official: Continent lacks infrastructure to run its own health AI| The New Times

Digital health is expanding across Africa, but countries are at different stages. Gaps in infrastructure, data governance and digital systems remain.

Read the original →

🇯🇵 Medicine and AI in Japan3

Think IT10/02 00:01 UTCJapanese

Google DeepMind's "CO-REDTEAM" Shows Future of Autonomous Vulnerability Assessment

This 14th installment explains how autonomous AI agents iteratively carry out and learn from vulnerability discovery through attack demonstration. It also covers their capabilities, risks and the impact on future security work.

Read the original →
Moomoo10/02 08:57 UTCJapanese

Moomoo AI Portfolio Diagnosis: Three Points to Watch Beyond Price Movements

The author used Moomoo AI for a comprehensive diagnosis of their actual holdings and found that ORCL made up about 53.6% of the portfolio. The tool also organized position concentration, cash liquidity and each holding's role, and noted the account's cash balance was zero. The author describes it as a supplementary analysis tool that is easy for beginners to use.

Read the original →
The analysis and visual summary are in the Oct 4 AM issue. Japanese version here.